A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia
Clinical trial NCT06821945 · RECRUITING
Trial details
- NCT number
- NCT06821945
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-30
- Primary completion
- 2027-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.